<code id='074B17E394'></code><style id='074B17E394'></style>
    • <acronym id='074B17E394'></acronym>
      <center id='074B17E394'><center id='074B17E394'><tfoot id='074B17E394'></tfoot></center><abbr id='074B17E394'><dir id='074B17E394'><tfoot id='074B17E394'></tfoot><noframes id='074B17E394'>

    • <optgroup id='074B17E394'><strike id='074B17E394'><sup id='074B17E394'></sup></strike><code id='074B17E394'></code></optgroup>
        1. <b id='074B17E394'><label id='074B17E394'><select id='074B17E394'><dt id='074B17E394'><span id='074B17E394'></span></dt></select></label></b><u id='074B17E394'></u>
          <i id='074B17E394'><strike id='074B17E394'><tt id='074B17E394'><pre id='074B17E394'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:3638

          Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do you pronounce bronchiectasis?

          This week on “The Readout LOUD,” we preview some of the research that will be presented at the American Society of Clinical Oncology conference in Chicago. We also discuss the latest news in the health and life sciences, including a milestone in lung disease R&D and a Duchenne muscular dystrophy confirmatory trial failure.  

          advertisement

          To read more about Merus’ combination therapy, go here; For more on Johnson & Johnson’s mixed data, click here; For more on Nippon Shinyaku’s Duchenne drug trial failure, go here; To read more on Insmed’s bronchiectasis treatment, click here; To sign up for STAT’s ASCO newsletter, click here.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          leisure time

          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more
          Why sickle cell disease is getting the first CRISPR treatment
          Why sickle cell disease is getting the first CRISPR treatment

          AdobeNearlyadecadeago,consultantsdeliveredtoRodgerNovakakindofSearscatalogofhumanmalady:200pages,lis

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          Medicare Advantage enrollment hits roughly 33.4 million

          AdobeYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followingtheflowofmoneyinmed